This Article Full Text Full Text (PDF) All Versions of this Article: 200807-1042PPv1 179/1/4    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nana-Sinkam, S. P. Articles by Marsh, C. B. Search for Related Content PubMed PubMed Citation Articles by Nana-Sinkam, S. P. Articles by Marsh, C. B.

Integrating the MicroRNome into the Study of Lung Disease

¹ Division of Pulmonary, Allergy, Critical Care and Sleep Medicine; ² Department of Pathology; and ³ Department of Pharmacology, Ohio State University Medical Center, Columbus, Ohio; ⁴ Battelle Memorial Institute, Columbus, Ohio; and ⁵ Institute for Systems Biology, Seattle, Washington

Correspondence and request for reprints should be addressed to S. Patrick Nana-Sinkam, M.D., Ohio State University Medical Center, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, DHLRI 473 West 12th Avenue, Room 201, Columbus, OH 43210. E-mail: Patrick.Nana-Sinkam{at}osumc.edu

ABSTRACT

Over the last 15 years, investigators have identified small noncoding RNAs as regulators of gene expression. One type of noncoding RNAs are termed microRNAs (miRNAs). miRNAs are evolutionary conserved, approximately 22-nucleotide single-stranded RNAs that target genes by inducing mRNA degradation or by inhibiting translation. miRNAs are implicated in many critical cellular processes, including apoptosis, proliferation, and differentiation. Furthermore, it is estimated that miRNAs may be responsible for regulating the expression of nearly one-third of the human genome. Despite the identification of greater than 500 mature miRNAs, very little is known about their biological functions and functional targets. In the last 5 years, researchers have increasingly focused on the functional relevance and role that miRNAs play in the pathogenesis of human disease. miRNAs are known to be important in solid organ and hematological malignancies, heart disease, as potential modulators of the immune response, and organ development. It is anticipated that miRNA analysis will emerge as an important complement to proteomic and genomic studies to further our understanding of disease pathogenesis. Despite the application of genomics and proteomics to the study of human lung disease, few studies have examined miRNA expression. This perspective is not meant to be an exhaustive review of miRNA biology but will provide an overview of both miRNA biogenesis and our current understanding of the role of miRNAs in lung disease as well as a perspective on the importance of integrating this analysis as a tool for identifying and understanding the biological pathways in lung-disease pathogenesis.

Key Words: microRNA • epigenetics • genomics

This article has been cited by other articles:

				Y. Chiba, M. Tanabe, K. Goto, H. Sakai, and M. Misawa Down-Regulation of miR-133a Contributes to Up-Regulation of RhoA in Bronchial Smooth Muscle Cells Am. J. Respir. Crit. Care Med., October 15, 2009; 180(8): 713 - 719. [Abstract] [Full Text] [PDF]